In particular, the 5′-long terminal repeat (LTR) region, which encodes the promoter that drives expression of the tax gene, is deleted in 28% of ATLL patients, compared with 4% ACs [25, 27, 28]. The gene discussed is CNTN2; the disease is adult T-cell leukemia/lymphoma.